In Brief: ATS' Dermatraft-TC
This article was originally published in The Gray Sheet
Executive Summary
ATS' Dermatraft-TC: Indications for use of human fibroblast-derived temporary skin substitute are expanded to include partial thickness (second-degree) burns, Advanced Tissue Sciences reports Oct. 20. The product was approved for severe burns in March; a PMA for treatment of diabetic foot ulcers is under expedited review at the agency...